Sign in

Research summary ·

Clomiphene citrate versus testosterone replacement therapy in male hypogonadism: a systematic review of literature and meta-analysis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study pooled the results of earlier studies on low testosterone in men. It looked at men whose bodies make too little testosterone. Some men took clomiphene citrate. Others got testosterone treatment. The team searched several research databases for such studies. The main goal was to see how much blood testosterone changed. They also looked at other hormones and at symptoms.

What they found

The review took in 11 studies with 1512 men. Of these, 764 took clomiphene and 748 took testosterone. Overall, there was no clear gap in blood testosterone between the treatments. In 8 studies using testosterone gel, results were also alike. In 1 study of 62 men, testosterone shots gave higher levels. Sex drive was checked in some studies with 199 men. Men on clomiphene had lower sex drive scores than men on testosterone.

What it means for patients

The authors saw no clear gap in testosterone levels between clomiphene and the gel. Testosterone treatment was linked to a larger gain in sex drive. The authors say these results should be seen as early. They call for large trials that also track fertility and symptoms.

Why it is not certain yet

The results of the studies varied a lot. Some studies had flaws that could bias their results. The shot result came from just 1 study. The sex drive finding came from only 199 men. A review can only be as good as the studies in it.

Source

Clomiphene citrate versus testosterone replacement therapy in male hypogonadism: a systematic review of literature and meta-analysis.

PubMed · PMID 42435198

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Male hypogonadism publications